BenevolentAI

BenevolentAI is a UK-founded biotech company that develops and applies AI and machine learning to accelerate drug discovery.

Its platform integrates knowledge graphs, proprietary ontologies, and large language models to identify novel therapeutic targets and design small molecule candidates across multiple disease areas.

The company operates through collaborations with pharmaceutical partners and maintains an internal drug pipeline.

It has research facilities in London and Cambridge.